Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
04/2007
04/26/2007WO2006135828A3 Trisubstituted amines as phosphodiesterase 4 inhibitors
04/26/2007WO2006117307B1 Benzotriazole derivatives as cannabinoid receptor antagonists
04/26/2007US20070093659 Methyl-2-[4-methyl-2-(1-methyl-piperidin-4-ylamino)-benzoimidazol-1-ylmethyl]-pyridin-3-ol; antiviral activity
04/26/2007US20070093537 Thiazolyl-based compounds useful as kinase inhibitors
04/26/2007US20070093535 Vinyl phenyl derivatives as GLK activators
04/26/2007US20070093534 Modulation of Pathogenicity
04/26/2007US20070093530 Substituted indolealkanoic acids
04/26/2007US20070093526 4-Amino-piperidine derivatives as monoamine uptake inhibitors
04/26/2007US20070093512 4-Phenylaminopyrido[4,3-d]pyrimidines 6-heteroaryl-substituted, in which the heteroaryl is substituted with a sulfonylethylamino-, thio- or oxy- group; protein tyrosine kinase inhibitors, used especially to treat various malignancies
04/26/2007US20070093506 Inhibitors of tyrosine kinases
04/26/2007US20070093501 Urea derivative, process for producing the same, and use
04/26/2007US20070093492 Pyrrolidine derivatives
04/26/2007US20070093488 Novel Benzothiazoles And The Use Thereof As Medicaments
04/26/2007US20070093485 Substituted n-phenyl sulfonamide bradykinin antagonists
04/26/2007US20070093483 Use of derivatives of 2, 4-dihydro-[1,2,4] triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo)
04/26/2007US20070093478 Novel mycobacterial inhibitors
04/26/2007US20070093477 Alpha2C adrenoreceptor agonists
04/26/2007US20070093472 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors xa and viia for the treatment of thromboses
04/26/2007US20070093467 2-(4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-1-[4-(4-fluorobenzyl),4-hydroxypiperidin-1-yl]ethanone; potent chemokine receptor antagonists; antiinflammatory agents; immunotherapy; rheumatic diseases; antiarthritic agents; transplant rejection; multiple sclerosis
04/26/2007US20070093454 sodium channel modulators, such as Isobutyl 4-(6-(2-hydroxyphenyl)pyrimidin-4-yl)piperazine-1-carboxylate, used as analgesics
04/26/2007US20070093430 Interferons; polyoxyethylene glycol
04/26/2007US20070092954 Production of polyketides
04/26/2007CA2626591A1 Amidine derivatives and their uses as medicine
04/26/2007CA2626568A1 Renin inhibitors nitroderivatives
04/26/2007CA2625423A1 Cb-1 modulating compounds and their use
04/26/2007CA2624831A1 Biphenyl derivatives as modulators of voltage gated ion channels
04/26/2007CA2624166A1 Inhibitors of viral replication
04/26/2007CA2624007A1 Acyl indoles, compositions containing such compounds and methods of use
04/25/2007EP1777225A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor
04/25/2007EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives
04/25/2007EP1776344A2 Quinoline derivatives as neurokinin receptor antagonists
04/25/2007EP1776337A2 Benzyloxy derivatives as maob inhibitors
04/25/2007EP1694646B1 Process for the synthesis of pioglitazone hydrogen chloride
04/25/2007EP1305294B1 Imidazolyl derivatives
04/25/2007EP1209151B1 4-substituted piperidine derivatives
04/25/2007EP1024138B1 Pyrazole derivatives
04/25/2007EP0949865A4 The use of cd4-binding small molecules to inhibit immune responses
04/25/2007EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors
04/25/2007CN1953976A Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
04/25/2007CN1953975A 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists
04/25/2007CN1953974A Pyrimidine derivatives for the treatment of abnormal cell growth
04/25/2007CN1953972A 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
04/25/2007CN1953968A Thiazole compound and use thereof
04/25/2007CN1951918A Substituted pyridine herbicides
04/25/2007CN1312148C Isochroman compounds for treatment of CNS disorders
04/25/2007CN1312139C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
04/25/2007CN1312138C Novel azoles having an insecticidal action
04/25/2007CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
04/25/2007CN1312136C Triazole derivatives as tachykinin receptor antagonists
04/24/2007US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2007US7208602 N-sulfonyl- azetidines, pyrrolidines, piperidines and hexamethylenimines; treatment and prevention of Alzheimer's Disease and other diseases relating to the deposition of amyloid protein.
04/24/2007US7208527 Potassium channel modulators
04/24/2007US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
04/24/2007US7208505 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group
04/24/2007US7208503 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
04/24/2007US7208496 Substituted heterocyclic compounds
04/24/2007US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling
04/24/2007US7208169 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
04/24/2007US7208141 Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections
04/24/2007CA2407763C Para-amine substituted phenylamide glucokinase activators
04/24/2007CA2307820C Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
04/24/2007CA2281545C N-heterocyclic derivatives as nos inhibitors
04/24/2007CA2194503C 2-[(dihydro)pyrazol-3'-yloxymethylene]anilides, their preparation and their use
04/24/2007CA2171934C Endothelin receptor antagonists
04/24/2007CA2075173C Compounds and methods for inhibition of hiv and related viruses
04/19/2007WO2007044515A1 Azetidines as mek inhibitors for the treatment of proliferative diseases
04/19/2007WO2007043677A1 Hydrazide compound and pesticidal use of the same
04/19/2007WO2007043653A1 Benzimidazole-5-carboxamide derivative
04/19/2007WO2007043638A1 Condensed heterocyclic compound
04/19/2007WO2007043457A1 Triarylcarboxylic acid derivative
04/19/2007WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
04/19/2007WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same
04/19/2007WO2007042912A2 Heterocyclic compounds as pstat3/il-6 inhibitors
04/19/2007WO2007042906A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands
04/19/2007WO2007042546A1 Imidazole derivatives for the treatment of anxiety and related diseases
04/19/2007WO2007042544A2 Imidazole derivatives and their use for modulating the gabaa receptor complex
04/19/2007WO2007042325A1 Antibacterial active 5-chinolin derivative
04/19/2007WO2007020050A3 Bicyclic bisamide derivatives and use thereof as insecticides
04/19/2007WO2007020050A2 Bicyclic bisamide derivatives and use thereof as insecticides
04/19/2007WO2007006534A3 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity
04/19/2007WO2006131340A3 Pyrrolones that act as peptide deformylase (pdf) inhibitors
04/19/2007WO2006101217A3 Luminous compound containing lanthanide ion
04/19/2007WO2006033005A8 Thrombopoietin receptor agonists
04/19/2007WO2005054186A3 Methods for the preparation of stereoisomerically enriched amines
04/19/2007US20070088159 Hydroxyalkyl cyclic diamine compounds
04/19/2007US20070088063 Alzheimer's disease; bridged bicycloalkyl spirocyclic sulphonamide derivatives; oral administration
04/19/2007US20070088062 N-[4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine; keratinization disorder such as rosacea, acne, and psoriasis; potent inhibitors of the retinoic acid-metabolism; show little or no endocrinological side-effects;
04/19/2007US20070088060 highly active active agents from the structural class of the epothilones and epothilone derivatives with suitable linkers; to link these epothilone-linker conjugates to recognition units, such as, for example, monoclonal antibodies or fragments thereof, to form immune conjugates
04/19/2007US20070088044 Quinazoline derivatives as antitumor agents
04/19/2007US20070088043 Novel HDAC inhibitors
04/19/2007US20070088042 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
04/19/2007US20070088037 Cancer and fibrotic diseases
04/19/2007US20070088033 Diaryl Substituted Pyridinones
04/19/2007US20070088028 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators
04/19/2007US20070088026 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi
04/19/2007US20070088020 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis
04/19/2007US20070088018 Cb1 antagonist compounds
04/19/2007US20070088017 Benzothiazole derivatives for the treatment of diabetes
04/19/2007US20070088016 5-substituted arylmethylidenyl (thio)xanthenes; hypotensive agents, antiinflammatory agents, antiarthritic agents; congestive heart failure
04/19/2007DE102005049385A1 Imidazolderivate als Inhibitoren von TAFIa Imidazole derivatives as inhibitors of TAFIa